119 related articles for article (PubMed ID: 37230295)
1. Programmed antigen capture-harnessed dendritic cells by margination-hitchhiking lung delivery.
Huynh TMH; Yalamandala BN; Chiang MR; Weng WH; Chang CW; Chiang WH; Liao LD; Liu YC; Hu SH
J Control Release; 2023 Jun; 358():718-728. PubMed ID: 37230295
[TBL] [Abstract][Full Text] [Related]
2. Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges.
Chiang MR; Shen WT; Huang PX; Wang KL; Weng WH; Chang CW; Chiang WH; Liu YC; Chang SJ; Hu SH
J Control Release; 2023 Aug; 360():260-273. PubMed ID: 37364798
[TBL] [Abstract][Full Text] [Related]
3. Lung metastasis-Harnessed in-Situ adherent porous organic nanosponge-mediated antigen capture for A self-cascaded detained dendritic cells and T cell infiltration.
Wu TH; Lu YJ; Chiang MR; Chen PH; Lee YS; Shen MY; Chiang WH; Liu YC; Chuang CY; Amy Lin HC; Hu SH
Biomaterials; 2024 Mar; 305():122443. PubMed ID: 38160627
[TBL] [Abstract][Full Text] [Related]
4. Marginative Delivery-Mediated Extracellular Leakiness and T Cell Infiltration in Lung Metastasis by a Biomimetic Nanoraspberry.
Shen WT; Hsu RS; Fang JH; Hu PF; Chiang CS; Hu SH
Nano Lett; 2021 Feb; 21(3):1375-1383. PubMed ID: 33562964
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
Chen J; Cao X; Xiu Q
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
[TBL] [Abstract][Full Text] [Related]
7. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.
DuPage M; Cheung AF; Mazumdar C; Winslow MM; Bronson R; Schmidt LM; Crowley D; Chen J; Jacks T
Cancer Cell; 2011 Jan; 19(1):72-85. PubMed ID: 21251614
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
9. Dendritic Cell-Based Immunotherapy in Lung Cancer.
Stevens D; Ingels J; Van Lint S; Vandekerckhove B; Vermaelen K
Front Immunol; 2020; 11():620374. PubMed ID: 33679709
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.
Yamaguchi Y; Ohta K; Kawabuchi Y; Ohshita A; Okita R; Okawaki M; Hironaka K; Matsuura K; Toge T
Anticancer Res; 2005; 25(3c):2407-15. PubMed ID: 16080467
[TBL] [Abstract][Full Text] [Related]
13. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
[TBL] [Abstract][Full Text] [Related]
14. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
[TBL] [Abstract][Full Text] [Related]
16. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
Brenner JS; Mitragotri S; Muzykantov VR
Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth control using red blood cells as the antigen delivery system and poly(I:C).
Banz A; Cremel M; Mouvant A; Guerin N; Horand F; Godfrin Y
J Immunother; 2012 Jun; 35(5):409-17. PubMed ID: 22576346
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of dendritic cell immunotherapy by recalling antigens for hepatocellular carcinoma in mice.
Lee WC; Cheng CH; Lee CF; Hsu HY; Hsu PY; Wu TJ; Chan KM
Immunotherapy; 2022 Oct; 14(15):1225-1236. PubMed ID: 36097695
[TBL] [Abstract][Full Text] [Related]
19. Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo.
Barratt-Boyes SM; Kao H; Finn OJ
J Immunother; 1998 Mar; 21(2):142-8. PubMed ID: 9551366
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant
Oba T; Kajihara R; Yokoi T; Repasky EA; Ito F
Cancer Res; 2021 Dec; 81(24):6183-6195. PubMed ID: 34666993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
